Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Molecular Cancer Research : MCR
|
July 15, 2018
Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations
Anthony C Wang, David T W Jones, Isaac Joshua Abecassis, et al.
Cancer Discovery
|
August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong, Guoxin Zhang, Meng Qu, et al.
Nature Genetics
|
November 26, 2013
Large conserved domains of low DNA methylation maintained by Dnmt3a
Mira Jeong, Deqiang Sun, Min Luo, et al.
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastoma
Meher Beigi Masihi, Kendall R Chambers, Richard A Friedman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2019
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
Sourav Banerjee, Tiantian Wei, Jue Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumors
Owen S Chapman, Sunita Sridhar, Eugene Yui-Ching Chow, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Neuro-Oncology
|
April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain
Johannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I Hwang, Marcel Kool, Peter C Burger, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Molecular Cancer Research : MCR
|
July 15, 2018
Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations
Anthony C Wang, David T W Jones, Isaac Joshua Abecassis, et al.
Cancer Discovery
|
August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong, Guoxin Zhang, Meng Qu, et al.
Nature Genetics
|
November 26, 2013
Large conserved domains of low DNA methylation maintained by Dnmt3a
Mira Jeong, Deqiang Sun, Min Luo, et al.
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastoma
Meher Beigi Masihi, Kendall R Chambers, Richard A Friedman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2019
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
Sourav Banerjee, Tiantian Wei, Jue Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumors
Owen S Chapman, Sunita Sridhar, Eugene Yui-Ching Chow, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Neuro-Oncology
|
April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain
Johannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I Hwang, Marcel Kool, Peter C Burger, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Page
of 8